FROMKIN ANDREW J. sold 20.6% of their position (22.25K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $517.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/3/2025ACC: 0001764013-25-000160
-22.25K
Net shares
Net seller
$517.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
22.25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−19.35K
Price / share
$23.14
Trade value
$447.78K
% of position
17.9%
12/1/2025
108.10K→88.75K
Common Stock
Direct
Shares
−2.90K
Price / share
$23.95
Trade value
$69.41K
% of position
3.3%
12/1/2025
88.75K→85.85K
Total
Net shares
−22.25K
Net value
-$517.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | S · Sale | −19.35K | $23.14 | $447.78K | 17.9% | 108.10K | 88.75K |
| Common Stock Direct | 12/1/2025 | S · Sale | −2.90K | $23.95 | $69.41K | 3.3% | 88.75K | 85.85K |
| Total | −22.25K | -$517.19K | ||||||
Derivative Transactions0
No derivative transactions reported